Going Past Your Due Date (Late-Term & Post-Term)

How risk changes from 40 to 42 weeks, what monitoring is offered, and how to decide about induction if labor hasn't started.

What it is

Only about 4% of babies are born on the exact due date. "Late-term" is 41w0d–41w6d; "post-term" is 42w0d and beyond. Stillbirth risk stays very low but rises slowly week by week after 40 weeks — from roughly 0.5 per 1,000 at 40 weeks to about 1–2 per 1,000 by 42 weeks. Cesarean risk, meconium, and macrosomia (bigger baby) also rise modestly. Most guidelines recommend offering induction between 41w0d and 42w0d, with twice-weekly monitoring (non-stress test + amniotic fluid check) in the meantime if you wait.

Evidence review links

Possible benefits

  • Waiting for spontaneous labor works about 70% of the time in the 41st week and avoids induction interventionsReview sources ↓
  • Twice-weekly monitoring catches most problems earlyReview sources ↓
  • Induction at 41 weeks reduces stillbirth risk and, in some trials, cesarean risk vs. waiting to 42 weeksReview sources ↓

Possible risks

  • Stillbirth risk rises each week past 40, especially past 41Review sources ↓
  • Higher rates of meconium-stained fluid, macrosomia, and shoulder dystociaReview sources ↓
  • Waiting past 42 weeks: monitoring is less protective and most guidelines advise against itReview sources ↓
  • Induction of an unfavorable cervix at 41+ weeks can still be a long processReview sources ↓

Alternatives

Run BRAIN with Labor LensGet Benefits, Risks, Alternatives, Intuition, and Nothing/Wait for Going Past Your Due Date (Late-Term & Post-Term) — plus questions for your care team.

Current evidence

ACOG Committee Opinion 831 (2021) recommends offering induction at 41w0d and advising delivery by 42w6d. A 2019 Cochrane review found induction at or beyond 41 weeks reduced perinatal death compared with expectant management. The SWEPIS trial (Sweden, 2019) was stopped early after more stillbirths in the expectant-management-to-42-weeks arm. WHO recommends induction by 41 weeks in low-risk pregnancies.

Where the evidence is clear · where people may choose differently

For most topics, guidelines from ACOG, WHO, and other major bodies broadly agree on the core safety points (when to act in an emergency, informed-consent standards, monitoring baselines). Where reasonable people — and even guidelines — differ tends to be around thresholds (when to start or stop something), preferences (comfort, environment, support), and values (how you weigh small risks against benefits). Use the questions below to explore those pieces with your care team.

Educational only. Your care team can help you weigh what applies to your specific situation.

Related evidence topics

Questions to ask your care team

  • ?What is my dating based on — LMP, first ultrasound, or both?
  • ?What are my options at 41 weeks vs. 41+3 vs. 42 weeks, and what do you recommend?
  • ?If we wait, what monitoring would we do and how often?
  • ?What would prompt you to recommend induction now rather than waiting?

Universal questions (works for any decision)

A short BRAIN-style set you can bring to any conversation about interventions, monitoring, or care decisions.

  • ?Why are you recommending this now — is it urgent, routine, or optional?
  • ?What happens if we wait an hour (or longer) before deciding?
  • ?What signs would tell us this is working — or that we need to change course?
  • ?What are the alternatives, including doing nothing?
  • ?What would you recommend if this were your family?
  • ?What would change your recommendation?

Sources & provenance

Further reading — canonical references

Read the source material directly. Each link opens the publisher's own current guidance in a new tab — cross-check what we summarize against what they say.

Educational only. Guidelines evolve — the linked publisher pages will reflect newer guidance than any static snapshot.

Version history — v1.0.0

  • v1.0.0 · 2026-07-03 · LlaMamma editors

    Initial post-dates topic — weekly risk, monitoring, 41-week decision.

New guidance from ACOG, WHO, Evidence Based Birth, or other listed sources is recorded here and can be updated remotely without a new app release.